25 May 2018
SCI's peer-reviewed journals provide commentary articles and research studies undertaken by top scientists in emerging areas while addressing global audiences by crossing academic, industrial, government and science policy sectors.
Here are some of the highlights from the June 2018 issues of our journals. To view the full range of SCI's journals, visit our Publications page!
Image: Gajus/Getty Images
Microvines as a plant model for grapevine analysis
Journal of the Science of Food and Agriculture DOI: 10.1002/jsfa.8802
The microvine plant model displays unique reproductive organ behaviour that is suitable for grapevine fruit physiological studies, which can be performed five times quicker than traditional methods. In this study, researchers looked at the effects of glycosylated aroma precursor accumulation in grapes.
Will research into malaria drugs help find new herbicides?
Pest Management Science DOI: 10.1002/ps.4872
To fight herbicide‐resistant weeds, new herbicides are needed – particularly ones with new modes of action. This paper looks at research linking antimalarial activity to herbicides – the parasitic protozoans Plasmodium spp. involved in malaria share an evolutionary relationship with plants. The study found that exploiting lead compounds that are often understudied could lead to the identification of potential new herbicidal agents.
Commercial challenges in developing biomaterials for medical device development
Polymer International DOI: 10.1002/pi.5590
Polymer International has launched a new series to address industry challenges. Building on SCI’s strong industrial links, Polymer International is working to increase communication and collaboration between academia and industry through the new series – Challenges to Industry. These articles will highlight the scientific challenges faced by academia and the commercial challenges faced by industry, helping to progress the polymer field and increase innovation and impact.
Available now, the first Challenges to Industry paper highlights the most important challenges faced in the biomaterials and medical device industry.